Why the study?
The relationship between uncoupling protein (UCP) 1-3 polymorphisms and susceptibility to type 2 diabetes mellitus had yielded contradictory conclusions.
Are UCP1-3826A/G, UCP2-866G/A, Ala55Val, and UCP3-55C/T polymorphisms associated with susceptibility to type 2 diabetes mellitus?
Are UCP1-3826A/G, UCP2-866G/A, Ala55Val, and UCP3-55C/T polymorphisms associated with susceptibility to type 2 diabetes mellitus?
The UCP2 Ala55Val polymorphism increases susceptibility to type 2 diabetes, whereas the UCP2-866G/A polymorphism is protective in Asian populations.
UCP2 Ala55Val and UCP3 variants were associated with T2DM risk in Asians; leaves open replication and causal validation before any screening use.
Background . The relationship between uncoupling protein (UCP) 1‐3 polymorphisms and susceptibility to type 2 diabetes mellitus (T2DM) has been extensively studied, while conclusions remain contradictory. Thus, we performed this meta‐analysis to elucidate whether the UCP1‐3826A/G, UCP2‐866G/A, Ala55Val, and UCP3‐55C/T polymorphisms are associated with T2DM. Methods . Eligible studies were searched from PubMed, Cochrane Library, and Web of Science database before 12 July 2020. Pooled odds ratios (ORs) with corresponding 95% confidence intervals (CIs) were calculated to evaluate the strength of the association. Heterogeneity analysis, subgroup analysis, sensitivity analysis, and publication bias were also performed. Results . A total of 38 case‐control studies were included in this meta‐analysis. The overall results revealed significant association between T2DM and the UCP2 Ala55Val polymorphism (recessive model: OR = 1.25, 95% CI 1.12‐1.40, P < 0.01; homozygous model: OR = 1.33, 95% CI 1.03‐1.72, P = 0.029, respectively). In subgroup analysis stratified by ethnicity, T2DM risk was increased with the UCP2 Ala55Val polymorphism (allele model: OR = 1.17, 95% CI 1.02‐1.34, P = 0.023; recessive model: OR = 1.28, 95% CI 1.13‐1.45, P < 0.01; homozygous model: OR = 1.39, 95% CI 1.05‐1.86, P = 0.023, respectively), while decreased with the UCP2‐866G/A polymorphism in Asians (dominant model: OR = 0.86, 95% CI 0.74‐1.00, P = 0.045). Conclusions . Our results demonstrate that the UCP2‐866G/A polymorphism is protective against T2DM, while the UCP2 Ala55Val polymorphism is susceptible to T2DM in Asians.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: